Register
News and Updates
eMediNexus Coverage from: 
WHO 2019 consolidated treatment guidelines on drug-resistant TB: Regimens for isoniazid-resistant TB
eMediNexus,  22 March 2019
remove_red_eye 733 Views
#Infectious Diseases #Pathology and Lab Medicine #Public Health

1 Read Comments                

In patients with confirmed rifampicin-susceptible and isoniazid-resistant tuberculosis, treatment with rifampicin, ethambutol, pyrazinamide and levofloxacin is recommended for duration of .In patients with confirmed rifampicin-susceptible and isoniazid-resistant tuberculosis, it is not recommended to add streptomycin or other injectable agents to the treatment regimen.(WHO)
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now